Implementation of the Nagoya Protocol: Recommendations of the German Medicines Manufacturers Association (BAH) for a Good Practice Guide regarding Regulation (EU) No 511/2014 of 16 Apr 2014.

Autor:	Waimer, Frank1, Torres-Londoño, Paula2, Stekly, Günter3, Wahrenburg, Frank4, Steinhoff, Barbara5 steinhoff@bah-bonn.de
Zdroj:	Pharmazeutische Industrie (Pharmind). 2018, Vol. 80 Issue 12, p1662-1667. 6p.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu